27006540|t|Addition of low-dose ketamine to midazolam and low-dose bupivacaine improves hemodynamics and postoperative analgesia during spinal anesthesia for cesarean section.
27006540|a|BACKGROUND AND AIMS: Spinal anesthesia for cesarean section (CS) is associated with an incidence of hypotension of 60-94%. This study hypothesizes that intrathecal combination of low-dose ketamine, midazolam, and low-dose bupivacaine improves hemodynamics and postoperative analgesia compared with fentanyl and low-dose bupivacaine during CS. MATERIAL AND METHODS: Fifty parturients undergoing elective CS were randomized equally to receive ketamine (10 mg), midazolam (2 mg) and 0.5% hyperbaric bupivacaine (8 mg) in group ketamine-midazolam-bupivacaine (KMB) or fentanyl (25 mug) and 0.5% hyperbaric bupivacaine (8 mg) in group fentanyl-bupivacaine (FB). Heart rate (HR), mean arterial blood pressure (MAP), oxygen saturation, sensorimotor block characteristics, pain-free period, side-effects including: hypotension, bradycardia, nausea, vomiting, sedation, pruritus, respiratory depression and dissociative manifestations, Apgar score at 1 and 5 min, and patients' satisfaction visual analog scores (VAS) were recorded. Patients in group KMB were followed for 6 months in order to assess any neurological disorder. RESULTS: Group KMB showed higher sensory level (P = 0.006), rapid sensory (P = 0.001) and motor (P = 0.005) onsets, prolonged sensory (P = 0.008) and motor (P = 0.002) blocks, and prolonged pain free period (P = 0.002). Ketamine-midazolam stabilized HR and MAP, and significantly reduced incidence of hypotension (P = 0.002), bradycardia (P = 0.013) and vomiting (P = 0.019). Apgar scores at 1 and 5 min were comparable in both groups (P = 0.699 and 0.646 respectively). Patients' satisfaction VAS scores were significantly higher in group KMB (P = 0.001). No patients in KMB group showed dissociative or neurotoxic manifestations. CONCLUSION: Intrathecal low-dose ketamine combined with midazolam and low-dose bupivacaine stabilizes hemodynamics and prolongs postoperative analgesia without significant side-effects in parturients undergoing CS.
27006540	21	29	ketamine	Chemical	MESH:D007649
27006540	33	42	midazolam	Chemical	MESH:D008874
27006540	56	67	bupivacaine	Chemical	MESH:D002045
27006540	265	276	hypotension	Disease	MESH:D007022
27006540	353	361	ketamine	Chemical	MESH:D007649
27006540	363	372	midazolam	Chemical	MESH:D008874
27006540	387	398	bupivacaine	Chemical	MESH:D002045
27006540	463	471	fentanyl	Chemical	MESH:D005283
27006540	485	496	bupivacaine	Chemical	MESH:D002045
27006540	606	614	ketamine	Chemical	MESH:D007649
27006540	624	633	midazolam	Chemical	MESH:D008874
27006540	661	672	bupivacaine	Chemical	MESH:D002045
27006540	689	697	ketamine	Chemical	MESH:D007649
27006540	698	707	midazolam	Chemical	MESH:D008874
27006540	708	719	bupivacaine	Chemical	MESH:D002045
27006540	721	724	KMB	Chemical	-
27006540	729	737	fentanyl	Chemical	MESH:D005283
27006540	767	778	bupivacaine	Chemical	MESH:D002045
27006540	795	803	fentanyl	Chemical	MESH:D005283
27006540	804	815	bupivacaine	Chemical	MESH:D002045
27006540	875	881	oxygen	Chemical	MESH:D010100
27006540	930	934	pain	Disease	MESH:D010146
27006540	972	983	hypotension	Disease	MESH:D007022
27006540	985	996	bradycardia	Disease	MESH:D001919
27006540	998	1004	nausea	Disease	MESH:D009325
27006540	1006	1014	vomiting	Disease	MESH:D014839
27006540	1026	1034	pruritus	Disease	MESH:D011537
27006540	1036	1058	respiratory depression	Disease	MESH:D012131
27006540	1124	1132	patients	Species	9606
27006540	1189	1197	Patients	Species	9606
27006540	1207	1210	KMB	Chemical	-
27006540	1261	1282	neurological disorder	Disease	MESH:D009461
27006540	1299	1302	KMB	Chemical	-
27006540	1474	1478	pain	Disease	MESH:D010146
27006540	1504	1512	Ketamine	Chemical	MESH:D007649
27006540	1513	1522	midazolam	Chemical	MESH:D008874
27006540	1585	1596	hypotension	Disease	MESH:D007022
27006540	1610	1621	bradycardia	Disease	MESH:D001919
27006540	1638	1646	vomiting	Disease	MESH:D014839
27006540	1755	1763	Patients	Species	9606
27006540	1824	1827	KMB	Chemical	-
27006540	1844	1852	patients	Species	9606
27006540	1856	1859	KMB	Chemical	-
27006540	1889	1914	neurotoxic manifestations	Disease	MESH:D020258
27006540	1949	1957	ketamine	Chemical	MESH:D007649
27006540	1972	1981	midazolam	Chemical	MESH:D008874
27006540	1995	2006	bupivacaine	Chemical	MESH:D002045
27006540	Cotreatment	MESH:D002045	MESH:D005283
27006540	Comparison	MESH:D005283	MESH:D007649
27006540	Negative_Correlation	MESH:D007649	MESH:D007022
27006540	Negative_Correlation	MESH:D008874	MESH:D014839
27006540	Association	MESH:D008874	MESH:D001919
27006540	Cotreatment	MESH:D007649	MESH:D008874
27006540	Cotreatment	MESH:D002045	MESH:D007649
27006540	Comparison	MESH:D005283	MESH:D008874
27006540	Cotreatment	MESH:D002045	MESH:D008874
27006540	Negative_Correlation	MESH:D007649	MESH:D001919
27006540	Negative_Correlation	MESH:D007649	MESH:D014839
27006540	Association	MESH:D008874	MESH:D007022

